Lamictal

Lamotrigine, the active ingredient in Lamictal, is an anticonvulsant presented as an oral tablet for oral use. It works by modulating neuronal excitability and is indicated for the treatment of partial and generalized seizures, as well as for long‑term mood stabilization in patients with bipolar disorder.

GNH USA supplies Lamictal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing and regulatory‑aligned distribution for global healthcare providers, including compliance with EU standards and export documentation.

Lamictal (lamotrigine) is used in the management of seizure disorders and mood stabilization, acting on neuronal excitability.

Partial seizures: reduces frequency and severity of focal onset seizures. Generalized seizures: helps control tonic‑clonic and other generalized seizure types. Bipolar disorder: provides maintenance therapy to prevent mood episode recurrence.

Lamictal may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often transient. - Dizziness: sensation of light‑headedness or imbalance. - Nausea: upset stomach or feeling of queasiness. - Rash: mild skin irritation or erythema.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: rare cases of agranulocytosis or pancytopenia.

Prior to initiating Lamictal, several precautionary measures should be considered to ensure safe use. - Baseline assessment: obtain complete medical history and baseline laboratory tests. - Skin monitoring: watch for any rash and discontinue if severe. - Drug interactions: review concomitant medications, especially enzyme inducers or inhibitors. - Pregnancy and lactation: discuss potential risks with healthcare provider. - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture.

Lamotrigine can interact with other medicines, affecting its plasma levels or safety profile.

Major Interactions (Avoid): - Valproic acid: markedly increases lamotrigine concentrations, risk of toxicity. - Carbamazepine: reduces lamotrigine levels, may diminish efficacy. - Phenobarbital: induces metabolism, lowering lamotrigine exposure.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may decrease lamotrigine levels, requiring dose adjustment. - Rifampin: enzyme inducer that can lower lamotrigine concentrations. - Serotonergic agents: combined use may increase risk of serotonin syndrome.